Brett Johnson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Brett Johnson

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

Urologic Oncology|January 21, 2025

Durability of response of UGN-101: Longitudinal follow up of multicenter studySolomon L Woldu, Daniel Igel, Brett Johnson, et al.

Urologic Oncology|July 30, 2023

First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.

Eclinicalmedicine|April 24, 2023

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conferenceMigena Luli, Giles Yeo, Emma Farrell, et al.

NPJ Precision Oncology|October 20, 2021

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.

Pageof 7

Search research articles

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

Urologic Oncology|January 21, 2025

Durability of response of UGN-101: Longitudinal follow up of multicenter studySolomon L Woldu, Daniel Igel, Brett Johnson, et al.

Urologic Oncology|July 30, 2023

First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumorsJoseph M Jacob, Solomon L Woldu, Jennifer Linehan, et al.

Eclinicalmedicine|April 24, 2023

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conferenceMigena Luli, Giles Yeo, Emma Farrell, et al.

NPJ Precision Oncology|October 20, 2021

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.

Pageof 7